Skip to main content
idi
Toggle navigation
0
You have 0 notifications
Site Visitor
Site Visitor
New To Inknowvation.com?
Register now to get an access to proprietary SBIR-STTR databases!
Registration is fast and free - start your access to business-actionable information today!
Login
Site Register
SBIR-STTR Award
You are here:
Home
Search Databases
Search SBIR-STTR Awards
SBIR-STTR Award
6
A Multiplexed Remote System for Filovirus Disease Surveillance
Award last edited on: 10/7/2019
Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$1,494,367
Award Phase
2
Solicitation Topic Code
NIAID
Principal Investigator
Neven Karlovac
Company Information
Holomic LLC
(
AKA
: Microskia Inc~Cellmic LLC)
10966 Le Conte Avenue
Los Angeles, CA 90024
(310) 443-2070
info@cellmic.com
www.cellmic.com
Location:
Single
Congr. District:
36
County:
Los Angeles
Phase I
Contract Number:
N/A
Start Date:
00/00/00
Completed:
00/00/00
Phase I year
2018
Phase I Amount
$1
Proposes an advanced Ebola and Marburg disease telemonitoring and assessment platform that will enable the digital modernization of point of care diagnosticsdisease surveillanceand healthcare screening by minimally trained personnel at the point of careOffering a complete diagnostics solutionthe platform includes a microfluidics assay for the detection of infections caused by Ebola and Marburg filovirusesa universal microfluidics reader and a unique telemonitoring service to communicate test results with HIPAA compliant remote database that can be accessed through a web interfaceThe testing process will takeminutes per patientand will require less than a drop of blood to performThe system will be validated with disease sera obtained from non human primateshuman sera from Ebola virus disease survivorsand field tested at a clinic in the Democratic Republic of CongoAlthough the primary focus of the project is the digital detection and monitoring of filovirus infectionsthe technology can be expanded for the detection of other infectionssuch as those caused by newly emerging virusesThis final integrated system will provide a rapidreliablereal time and digital solution for remote monitoring of Ebola and Marburg virus diseasesThe phase II efforts to further advance development of this platform will optimize the system sensitivity and accuracycreate user friendly interfaces and procedures for field operationsand refine the system specifications to address technical and market requirements to reach a successful product launch
Phase II
Contract Number:
272201800055C-0-0-0
Start Date:
00/00/00
Completed:
00/00/00
Phase II year
2018
Phase II Amount
$1,494,366
Proposes an advanced Ebola and Marburg disease telemonitoring and assessment platform that will enable the digital modernization of point of care diagnosticsdisease surveillanceand healthcare screening by minimally trained personnel at the point of careOffering a complete diagnostics solutionthe platform includes a microfluidics assay for the detection of infections caused by Ebola and Marburg filovirusesa universal microfluidics reader and a unique telemonitoring service to communicate test results with HIPAA compliant remote database that can be accessed through a web interfaceThe testing process will takeminutes per patientand will require less than a drop of blood to performThe system will be validated with disease sera obtained from non human primateshuman sera from Ebola virus disease survivorsand field tested at a clinic in the Democratic Republic of CongoAlthough the primary focus of the project is the digital detection and monitoring of filovirus infectionsthe technology can be expanded for the detection of other infectionssuch as those caused by newly emerging virusesThis final integrated system will provide a rapidreliablereal time and digital solution for remote monitoring of Ebola and Marburg virus diseasesThe phase II efforts to further advance development of this platform will optimize the system sensitivity and accuracycreate user friendly interfaces and procedures for field operationsand refine the system specifications to address technical and market requirements to reach a successful product launch
×
Login to your account
Mail sent successfully.
Enter any username and password.
Username
Password
Remember me
Login
Forgot your username?
Click here for assistance
Forgot your password?
Request new password
Don't have an account?
Sign up
Forgot username?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.
Forgot password?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.